FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Arm patents



      
           
This page is updated frequently with new Arm-related patent applications. Subscribe to the Arm RSS feed to automatically get the update: related Arm RSS feeds. RSS updates for this page: Arm RSS RSS


Needle safety device

Date/App# patent app List of recent Arm-related patents
09/25/14
20140289745
 Intelligent alarm manipulator and resource tracker patent thumbnailnew patent Intelligent alarm manipulator and resource tracker
Systems and methods for tracking resources used by triggers such as alarms and timers that are used by mobile applications to schedule tasks and intelligently manipulating the timing of the triggers to optimize usage of resources such as, but not limited to: network, battery, cpu and/or memory are disclosed. In one embodiment, an intelligent alarm manipulator and resource tracker tracks triggers from multiple applications on a mobile device and corresponding use of resources resulting from the triggers on a mobile device.
09/25/14
20140288972
 Systems and methods for providing an inducement to purchase incident to a physician's prescription of medication patent thumbnailnew patent Systems and methods for providing an inducement to purchase incident to a physician's prescription of medication
Systems and methods for providing targeted content to a patient who has received a prescription for medication. The systems and methods generally provide the content prior to the point of sale (pos) of the actual prescription allow patients to review the content and possibly act on it prior to actually obtaining the medication.
09/25/14
20140288956
 Systems and methods for providing an inducement of a purchase in conjunction with a prescription patent thumbnailnew patent Systems and methods for providing an inducement of a purchase in conjunction with a prescription
Systems and methods for providing targeted content to a patient who has received a prescription for medication. The systems and methods generally provide the content prior to the point of sale (pos) of the actual prescription to allow patients to review the content and possibly act on it prior to actually obtaining the medication.
09/25/14
20140288513
 Needle safety device patent thumbnailnew patent Needle safety device
Described is a needle safety device comprising a needle hub including an axial stem having one or more grooves, a needle having a distal tip, a needle shield telescopically coupled to the needle hub and including a first aperture for allowing the needle to pass through, and an inner sleeve rotatably coupled to the needle shield and including a second aperture for allowing the needle to pass through. The inner sleeve includes one or more resilient arms adapted to engage the groove.
09/25/14
20140288334
 Novel resveratrol polymerization compound or pharmaceutically acceptable salt thereof patent thumbnailnew patent Novel resveratrol polymerization compound or pharmaceutically acceptable salt thereof
This invention relates to a resveratrol polymerization compound represented by formula (1) (in which, in formula (1), r1 and r2 represent —oh or formula (2) and r1 and r2 are not the same) or a pharmaceutically acceptable salt thereof and an anticancer agent, an anticancer agent for oral cancer, an antioxidant, an antibacterial agent, a lipase inhibitor, an antiobesity agent, a therapeutic agent for skin diseases, a food, a pharmaceutical agent, a quasi drug, or a cosmetic containing one or more compounds selected from the group consisting of the resveratrol polymerization compound and the pharmaceutically acceptable salt thereof.. .
09/25/14
20140288302
 Acetic acid amide derivative having inhibitory activity on endothelial lipase patent thumbnailnew patent Acetic acid amide derivative having inhibitory activity on endothelial lipase
Its pharmaceutically acceptable salt, or a solvate thereof. Ring a is nitrogen-containing hetero ring, ring a may be substituted with a substituent other than a group represented by formula: —c(r1r2)—c(═o)—nr3r4 and a group represented by formula: —r5, a broken line represents presence or absence of a bond, z is —nr6—, ═n—, —o—, or —s—, r6 is halogen or substituted or unsubstituted alkyl, r1 and r2 are each independently hydrogen, halogen, hydroxy, cyano, nitro, carboxy or substituted or unsubstituted alkyl, r3 is hydrogen or substituted or unsubstituted alkyl, r4 is hydrogen or substituted or unsubstituted alkyl, r3 and r4 taken together with the adjacent nitrogen atom to which they are attached may form a substituted or unsubstituted ring, r5 is hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, or substituted or unsubstituted alkynyl..
09/25/14
20140288183
 Compounds and compositions for use a modulators of tau aggregation and alleviation of tauopathies patent thumbnailnew patent Compounds and compositions for use a modulators of tau aggregation and alleviation of tauopathies
This invention relates to the use of bis- and tris-dihydroxyaryl compounds as well as sulfonamides, heteroaryls, tricycloalkyl and their analogs and pharmaceutically acceptable salts, for modulating tau aggregation and alleviating tauopathies, such as alzheimer's disease (ad), pick's disease (pid), progressive supranuclear palsy (psp), corticobasal degeneration (cbd) and familial frontotemporal dementia/parkinsonism linked to chromosome 17 (ftdp-17), amyotrophic lateral sclerosis/parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.. .
09/25/14
20140288141
 Prmt1 inhibitors and uses thereof patent thumbnailnew patent Prmt1 inhibitors and uses thereof
Described herein are compounds of formula (i), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting prmt1 activity.
09/25/14
20140288140
 Prmt1 inhibitors and uses thereof patent thumbnailnew patent Prmt1 inhibitors and uses thereof
Described herein are compounds of formula (i), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting prmt1 activity.
09/25/14
20140288135
 Aminoalkyloxazole and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissues patent thumbnailnew patent Aminoalkyloxazole and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissues
A method of treating inner ear hardness of hearing and restoring hearing of humans and animals after damage and loss of sensory hair cells in an organ of corti based on regeneration biology includes administering a therapeutically effective amount of a compound including aminoalkyloxazole and aminoalkylthiazole carboxylic acid amides, or a pharmaceutically acceptable salt, a stereoisomer, a stereoisomer mixture, a tautomer or a prodrug compound thereof, directly or indirectly to damaged tissue structures in a cochlea, optionally, by transtympanal injection into a middle ear, by application to a round or oval window of an inner ear or by injection into the inner ear.. .
09/25/14
20140288132
new patent Hydroxybenzoate salts of metanicotine compounds
Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of e-metanicotine-type compounds. The formation of hydroxybenzoate salts of the e-metanicotine compounds is also useful in purifying the e-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as z-metanicotine compounds, and compounds where the double bond has migrated, in solution.
09/25/14
20140288129
new patent Prmt1 inhibitors and uses thereof
Described herein are compounds of formula (i-a) and (i-b), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting prmt1 activity.
09/25/14
20140288128
new patent Arginine methyltransferase inhibitors and uses thereof
Described herein are compounds of formula (i), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting arginine methyltransferase activity.
09/25/14
20140288127
new patent Novel alkene oxindole derivatives
As well as pharmaceutically acceptable salt thereof, wherein r1 to r7 have the significance given herein. The compounds are useful in the treatment of prophylaxis of diseases that are related to ampk regulation..
09/25/14
20140288125
new patent N-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia
The present invention relates to a method of treating chronic myelogenous leukemia in a subject comprising administering to the subject a compound, such as n-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide, that inhibits the t315i mutation in bcr-abl tyrosine kinase, or a pharmaceutically acceptable salt thereof. The present invention also relates to a pharmaceutical composition comprising a compound such as n-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl]-benzamide, that inhibits the t315i mutation in bcr-abl tyrosine kinase, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent..
09/25/14
20140288124
new patent Arginine methyltransferase inhibitors and uses thereof
Described herein are compounds of formula (i), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting arginine methyltransferase activity.
09/25/14
20140288119
new patent Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
Or a pharmaceutically acceptable salt thereof.. .
09/25/14
20140288111
new patent N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
Or a pharmaceutically acceptable salt of the compound, wherein r1, r2, r3 and r4 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-coa carboxylase enzyme(s) in an animal.. .
09/25/14
20140288109
new patent Mk2 inhibitors
The present invention relates to compounds of general formula (i) or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of immune, autoimmune, inflammatory diseases, cardiovascular diseases, infectious diseases, bone resorption disorders, neurodegenerative diseases or proliferative diseases..
09/25/14
20140288105
new patent Arginine methyltransferase inhibitors and uses thereof
Described herein are compounds of formula (i), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting arginine methyltransferase activity.
09/25/14
20140288101
new patent 3-(substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
The invention provides 3-deuterium-enriched 3-(6-, 7-, or 8-substituted-4-oxoquinazolin-3(4h)-yl)-piperidine-2,6-diones, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same.. .
09/25/14
20140288099
new patent Composition
Compound (i), and pharmaceutically acceptable salts thereof, are inducers of human interferon. Certain discrete and particular dosages of compound (i) may be particularly useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and allergic asthma..
09/25/14
20140288094
new patent Pyrazolopyridyl compounds as aldosterone synthase inhibitors
Or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthase.
09/25/14
20140288092
new patent Heteroaryl compounds as sodium channel blockers
The invention relates to aryl substituted compounds of formula (i): and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein het, g, a, r, and n are defined as set forth in the specification. The invention is also directed to the use of compounds of formula i to treat a disorder responsive to the blockade of sodium channels.
09/25/14
20140288089
new patent 1-(2-phenoxymethylphenyl)piperazine compounds
Where a, and r1 through r6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula i are serotonin and norepinephrine reuptake inhibitors.
09/25/14
20140288088
new patent Inhibitors of the renal outer medullary potassium channel
And the pharmaceutically acceptable salts thereof, which are inhibitors of the romk (kir1.1) channel. The compounds act as diuretics and natriuretics and are valuable pharmaceutically active compounds for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension and conditions resulting from excessive salt and water retention..
09/25/14
20140288079
new patent Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction
The present invention relates to soluble guanylate cyclase (sgc) and to phosphodiesterases (pdes) and the pharmacology of sgc stimulators, sgc activators and pde inhibitors. More particularly, the invention relates to the use of sgc stimulators and sgc activators in combination with pde5 inhibitors for preparation of medicaments for the treatment of male erectile dysfunction (med) in particular for the med treatment of difficult to treat patients and patients not or not fully responding to pde5 inhibitors..
09/25/14
20140288076
new patent Heteroaryl compounds and their uses
And pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a disease or condition mediated by cdk9..
09/25/14
20140288075
new patent Isoxazole compound for the treatment of cancer
The use of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide or a tautomer thereof or a pharmaceutically acceptable salt or a hydrate or a solvate for the treatment of cancer of the bladder, the colon, the liver, the lung, the breast, the vagina, the ovaries, the pancreas, the kidney, the stomach, the gastrointestinal tract, the prostate, the head and neck, the peritoneal cavity, the thyroid, the bone, the brain, the central nervous system and/or the blood and/or for the treatment of myelodysplastic syndrome, systemic mastocytosis, von hippel-lindau syndrome, multicentric castleman disease and/or psioriasis.. .
09/25/14
20140288072
new patent 5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester-transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis
The present application relates to a series of substituted pyra-zolopyridin-6-amines having the general formula (i), including their stereoisomers and/or their pharmaceutically acceptable salts. Wherein r, r1, r2, ra, raa, rb and n are as defined herein.
09/25/14
20140288063
new patent Heterocyclic substituted pyrimidine compound
The present invention pertains to the field of medical technology, and particularly relates to a heterocyclic substituted pyrimidine compound represented by general formula (i) and its pharmaceutically acceptable salt thereof, wherein r1, r2, r3, r4 and r5 are as defined in the description, the present invention also relates to a preparation method of the compound, a pharmaceutical composition containing the compound, and a use of the compound and the pharmaceutical composition in preparation of a medicine for enhancing a cgmp signal transduction function or a medicine for treating or preventing sexual dysfunction and diseases with lower urinary tract symptoms.. .
09/25/14
20140288060
new patent Selective inhibition of malt1 protease by phenothiazine derivatives
Wherein x is n or c; y is s, o, so2, so, nh, co, ch2, ch═ch, ch2═ch2; ( )z is a c1-c5 linear or branched alkyl chain; a is nr3r4, or or5, or het; r1 and r2 in each occurrence are independently selected from —h, —ch3, —oh, —och3, —sch3, —f, —cl, —cf3, —nh2, and —cooh; r3, r4, and r5 are h, or c1-c5 linear or branched alkyl groups, and het is a heterocyclic ring of 5, 6, or 7 members, wherein the ring atoms can be c, o, n, or s, the ring can be saturated or aromatic, and the ring can be substituted with h or c1-c5 linear or branched alkyl groups; or a pharmaceutically acceptable salt, prodrug, enantiomer, diastereomer, racemic mixture, crystalline form, amorphous form, unsolvated form or solvate of said compound. The compound of the invention may further be used in the treatment of malt1-dependent immune diseases..
09/25/14
20140288050
new patent Modulators of opioid receptors and methods of use thereof
Provided herein are compounds and methods of synthesis thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as pain, neurological disorders, psychiatric disorders, and neuromuscular disorders.
09/25/14
20140288047
new patent Benzoxazepin pi3k inhibitor compounds and methods of use
Benzoxazepin compounds of formula i, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, wherein: z1 is cr1 or n; z2 is cr2 or n; z3 is cr3 or n; z4 is cr4 or n; and b is a pyrazolyl, imidazolyl, or triazolyl ring fused to the benzoxepin ring, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of pi3k, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of formula i for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed..
09/25/14
20140288042
new patent Inhibitors of the renal outer medullary potassium channel
Wherein r represents a fused bicyclic or spirocyclic aliphatic diamine and pharmaceutically acceptable salts thereof which are inhibitors of the renal outer medullary potassium (romk) channel (kir1.1). The compounds are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure..
09/25/14
20140288031
new patent Methods of treating heavy menstrual bleeding
The present invention relates to the method of treating heavy menstrual bleeding in a subject with or without uterine fibroids and in need of treatment by administering an effective amount of 4-((r)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2h-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens.. .


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Arm for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Arm with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.1463

6834

1 - 1 - 104